Founded in 1992, Guangzhou Wondfo Biotech Co., Ltd., known as Wondfo, is a leading player in the in vitro diagnosis (IVD) industry with approximately 2,500 employees based in Guangzhou science city. Listed on the GEM of Shenzhen Stock Exchange in 2015, Wondfo specializes in the research, development, production, and distribution of point-of-care testing (POCT) products, offering customers innovative solutions for rapid diagnosis and chronic disease management.
With a strong commitment to providing professional healthcare solutions, Wondfo focuses on delivering high-quality POCT products to meet the evolving needs of the medical community. As the first POCT share in China, Wondfo continues to drive advancements in the industry, ensuring efficient and reliable diagnostic tools for improved patient care.
Generated from their website's infomation